Works matching IS 0008543X AND DT 2006 AND VI 106 AND IP 11

Results: 33

A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of life.

Published in:

2006

By:

Samuelsson, Jan;
Hasselbalch, Hans;
Bruserud, Oystein;
Temerinac, Snezana;
Brandberg, Yvonne;
Merup, Mats;
Linder, Olle;
Bjorkholm, Magnus;
Pahl, Heike L;
Birgegard, Gunnar;
Nordic Study Group for Myeloproliferative Disorders

Publication type:

journal article

Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma.

Published in:

2006

By:

Hwu, Wen-Jen;
Panageas, Katherine S;
Menell, Jennifer H;
Lamb, Lynne A;
Aird, Suzan;
Krown, Susan E;
Williams, Linda J;
Chapman, Paul B;
Livingston, Philip O;
Wolchok, Jedd D;
Houghton, Alan N

Publication type:

journal article

Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells.

Published in:

2006

By:

Wang, Zhiwei;
Zhang, Yuxiang;
Banerjee, Sanjeev;
Li, Yiwei;
Sarkar, Fazlul H

Publication type:

journal article

Erratum: Tanvetyanon T. Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy. Cancer. 2005; 103(2):237–41.

Published in:: Cancer (0008543X), 2006, v. 106, n. 11, p. 2530
Publication type:: Article

Author reply.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2529

By:

Nikolaus Lubomierski;
Guido Plotz;
Jochen Raedle

Publication type:

Article

Once daily, oral, outpatient quinolone monotherapy for low‐risk cancer patients with fever and neutropeniaThese data were presented in part as abstract 375 at the 41st Annual Meeting of the Infectious Diseases Society of America, San Diego, California, October 9‐12, 2003.: A pilot study of 40 patients based on validated risk‐prediction rules

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2489

By:

Kenneth V. I. Rolston;
Ellen F. Manzullo;
Linda S. Elting;
Susan E. Frisbee‐Hume;
Leslie McMahon;
Richard L. Theriault;
Shreyaskumar Patel;
Robert S. Benjamin

Publication type:

Article

Generalizability of cancer clinical trial resultsPresented in part at the 38th Annual Meeting of the American Society of Clinical Oncology, May 18‐21, 2002, Orlando, Florida.The funding entities were not involved in the design or conduct of the study, analysis of results, interpretation of findings, or preparation of this report.: Prognostic differences between participants and nonparticipants

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2452

By:

Linda S. Elting;
Catherine Cooksley;
B. Nebiyou Bekele;
Michael Frumovitz;
Elenir B. C. Avritscher;
Charlotte Sun;
Diane C. Bodurka

Publication type:

Article

Randomized trial of high‐dose chemotherapy and autologous hematopoietic stem cell support for high‐risk primary breast carcinoma: Follow‐up at 12 years.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2327

By:

Emer O. Hanrahan;
Kristine Broglio;
Deborah Frye;
Aman U. Buzdar;
Richard L. Theriault;
Vicente Valero;
Daniel J. Booser;
Sonja E. Singletary;
Eric A. Strom;
James L. Gajewski;
Richard E. Champlin;
Gabriel N. Hortobagyi

Publication type:

Article

Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5‐Aza‐2′‐deoxycytidine.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2514

By:

Makoto Arai;
Osamu Yokosuka;
Yuichi Hirasawa;
Kenichi Fukai;
Tetsuhiro Chiba;
Fumio Imazeki;
Tatsuo Kanda;
Mari Yatomi;
Yuichi Takiguchi;
Naohiko Seki;
Hiromitsu Saisho;
Takenori Ochiai

Publication type:

Article

Phase II study of temozolomide plus pegylated interferon‐α‐2b for metastatic melanomaPresented in part at the 39th American Society of Clinical Oncology Annual Meeting in New Orleans, Louisiana, June 5‐8, 2004.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2445

By:

Wen‐Jen Hwu;
Katherine S. Panageas;
Jennifer H. Menell;
Lynne A. Lamb;
Suzan Aird;
Susan E. Krown;
Linda J. Williams;
Paul B. Chapman;
Philip O. Livingston;
Jedd D. Wolchok;
Alan N. Houghton

Publication type:

Article

BRAF mutations in colorectal carcinoma suggest two entities of microsatellite‐unstable tumors.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2528

By:

Eduardo Vilar;
Judith Balmaña;
Eloy Espín

Publication type:

Article

Cancer‐specific survival and predictors of prostate‐specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomyPresented in part at the American Urological Association Meeting, San Antonio, Texas, May 21–26, 2005.This original study received the American Society of Clinical Oncology's Merit Award at the Prostate Cancer Symposium, 2005.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2369

By:

Fernando P. Secin;
Fernando J. Bianco;
Andrew J. Vickers;
Victor Reuter;
Thomas Wheeler;
Paul A. Fearn;
James A. Eastham;
Peter T. Scardino

Publication type:

Article

Characteristics of patients and predictors of in‐hospital mortality after hospitalization for head and neck cancers.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2382

By:

Veerasathpurush Allareddy;
Badrinath R. Konety

Publication type:

Article

High‐risk cutaneous squamous cell carcinoma of the head and neckPresented as an oral presentation at the 56th Annual Scientific Meeting of the Royal Australian and New Zealand College of Radiologists, Sydney, Australia, October 6–9, 2005.: Results from 266 treated patients with metastatic lymph node disease

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2389

By:

Michael J. Veness;
Carsten E. Palme;
Gary J. Morgan

Publication type:

Article

Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2363

By:

Tetsuro Tsukamoto;
Junji Yonese;
Yuhei Ohkubo;
Iwao Fukui

Publication type:

Article

Quality of life in long‐term survivors of bladder cancer.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2355

By:

Veerasathpurush Allareddy;
Julianna Kennedy;
Michele M. West;
Badrinath R. Konety

Publication type:

Article

A phase II trial of pegylated interferon α‐2b therapy for polycythemia vera and essential thrombocythemiaData management and statistical analyses were performed by Hans Garmo and Gunilla Juhlin at the regional Oncologic Center in Uppsala, Sweden.: Feasibility, clinical and biologic effects, and impact on quality of life

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2397

By:

Jan Samuelsson;
Hans Hasselbalch;
Oystein Bruserud;
Snezana Temerinac;
Yvonne Brandberg;
Mats Merup;
Olle Linder;
Magnus Bjorkholm;
Heike L. Pahl;
Gunnar Birgegard

Publication type:

Article

Patterns and predictors of mammography utilization among breast cancer survivors.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2482

By:

Chyke A. Doubeni;
Terry S. Field;
Marianne Ulcickas Yood;
Sharon J. Rolnick;
Charles P. Quessenberry;
Hassan Fouayzi;
Jerry H. Gurwitz;
Feifei Wei

Publication type:

Article

Impact of age on outcome of pediatric acute myeloid leukemiaPresented in part at the 46th Annual Meeting of the American Society of Hematology, December 5, 2004, San Diego, CA.: A report from 2 institutions.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2495

By:

Bassem I. Razzouk;
Elihu Estey;
Stanley Pounds;
Shelly Lensing;
Sherry Pierce;
Mark Brandt;
Jeffrey E. Rubnitz;
Raul C. Ribeiro;
Michael Rytting;
Ching‐Hon Pui;
Hagop Kantarjian;
Sima Jeha

Publication type:

Article

Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2428

By:

Anne S. Tsao;
Diane Liu;
J. Jack Lee;
Margaret Spitz;
Waun Ki Hong

Publication type:

Article

Volume and process of care in high‐risk cancer surgeryThe views expressed herein do not necessarily represent the views of Center for Medicare and Medicaid Services or the US Government.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2476

By:

John D. Birkmeyer;
Yating Sun;
Aaron Goldfaden;
Nancy J.O. Birkmeyer;
Therese A. Stukel

Publication type:

Article

Phase II study of mitoxantrone and ketoconazole for hormone‐refractory prostate cancer.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2459

By:

John Eklund;
Mark Kozloff;
Joy Vlamakis;
Alexander Starr;
Margaret Mariott;
Lilia Gallot;
Borko Jovanovic;
Lawrence Schilder;
Erwin Robin;
Michael Pins;
Raymond C. Bergan

Publication type:

Article

The “y” symbol: An important classification tool for neoadjuvant cancer treatment.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2526

By:

James D. Brierley;
Frederick L. Greene;
Leslie H. Sobin;
Christian Wittekind

Publication type:

Article

Health insurance coverage and cost barriers to needed medical care among U.S. adult cancer survivors age <65 yearsThe findings and conclusions in this report are those of the authors and do not necessarily represent the views of the funding agency.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2466

By:

Susan A. Sabatino;
Ralph J. Coates;
Robert J. Uhler;
Linda G. Alley;
Lori A. Pollack

Publication type:

Article

Estrogen‐based hormone therapy and thrombosis risk in women with essential thrombocythemia.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2406

By:

Naseema Gangat;
Alexandra P. Wolanskyj;
Susan M. Schwager;
Ruben A. Mesa;
Ayalew Tefferi

Publication type:

Article

Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non‐hodgkin lymphoma.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2412

By:

Constantine S. Tam;
Max Wolf;
H. Miles Prince;
E. Henry Januszewicz;
David Westerman;
Katherine I. Lin;
Dennis Carney;
John F. Seymour

Publication type:

Article

Dietary selenium intake, aldehyde dehydrogenase‐2 and X‐ray repair cross‐complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2345

By:

Lin Cai;
Nai‐Chieh Yuko You;
Hua Lu;
Li‐Na Mu;
Qing‐Yi Lu;
Shun‐Zhang Yu;
Anh D. Le;
James Marshall;
David Heber;
Zuo‐Feng Zhang

Publication type:

Article

Benefit of taxanes as adjuvant chemotherapy for early breast cancerPresented as a Poster Discussion at the European Cancer Conference (ECCO), Paris, France, October 30th to November 3rd, 2005.: Pooled analysis of 15,500 patients.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2337

By:

Emilio Bria;
Cecilia Nistico;
Federica Cuppone;
Paolo Carlini;
Mariangela Ciccarese;
Michele Milella;
Guido Natoli;
Edmondo Terzoli;
Francesco Cognetti;
Diana Giannarelli

Publication type:

Article

Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum‐based chemotherapy in advanced nonsmall cell lung cancer.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2421

By:

Richard Booton;
Tim Ward;
Jim Heighway;
Pat Taylor;
Fiona Power;
Linda Ashcroft;
Julie Morris;
Nicholas Thatcher

Publication type:

Article

Association between adiponectin, insulin resistance, and endometrial cancer.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2376

By:

Pamela T. Soliman;
Diana Wu;
Guillermo Tortolero‐Luna;
Kathleen M. Schmeler;
Brian M. Slomovitz;
Molly S. Bray;
David M. Gershenson;
Karen H. Lu

Publication type:

Article

Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2318

By:

Mieke Kriege;
Cecile T. M. Brekelmans;
Carla Boetes;
Sara H. Muller;
Harmine M. Zonderland;
Inge Marie Obdeijn;
Radu A. Manoliu;
Theo Kok;
Emiel J. T. Rutgers;
Harry J. de Koning;
Jan G. M. Klijn

Publication type:

Article

Biologic and immunomodulatory events after CTLA‐4 blockade with ticilimumab in patients with advanced malignant melanomaPresented in part at the 2005 Annual Meeting of the American Society of Clinical Oncology.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2437

By:

James M. Reuben;
Bang‐Ning Lee;
Changping Li;
Jesus Gomez‐Navarro;
Viviana A. Bozon;
Charla A. Parker;
Ingrid M. Hernandez;
Carolina Gutierrez;
Gabriel Lopez‐Berestein;
Luis H. Camacho

Publication type:

Article

Evaluation of the HER2/neu‐derived peptide GP2 for use in a peptide‐based breast cancer vaccine trialThis article is a US Government work and, as such, is in the public domain in the United States of America.The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or reflecting the views of the Department of the Army or the Department of Defense.

Published in:

Cancer (0008543X), 2006, v. 106, n. 11, p. 2309

By:

Elizabeth A. Mittendorf;
Catherine E. Storrer;
Rebecca J. Foley;
Katie Harris;
Yusuf Jama;
Craig D. Shriver;
Sathibalan Ponniah;
George E. Peoples

Publication type:

Article